CLINICAL TRIALS PROFILE FOR DIFLUCAN IN SODIUM CHLORIDE 0.9%
✉ Email this page to a colleague
All Clinical Trials for Diflucan In Sodium Chloride 0.9%
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00075803 ↗ | Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) | Completed | Blood and Marrow Transplant Clinical Trials Network | Phase 3 | 2003-11-01 | The study is designed as a Phase III, randomized, double-blind, multicenter, prospective, comparative study of fluconazole versus voriconazole for the prevention of fungal infections in allogeneic transplant recipients. Recipients will be stratified by center and donor type (sibling vs. unrelated) and will be randomized to either the fluconazole or voriconazole arm in a 1:1 ratio. |
| NCT00075803 ↗ | Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) | Completed | National Cancer Institute (NCI) | Phase 3 | 2003-11-01 | The study is designed as a Phase III, randomized, double-blind, multicenter, prospective, comparative study of fluconazole versus voriconazole for the prevention of fungal infections in allogeneic transplant recipients. Recipients will be stratified by center and donor type (sibling vs. unrelated) and will be randomized to either the fluconazole or voriconazole arm in a 1:1 ratio. |
| NCT00075803 ↗ | Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 2003-11-01 | The study is designed as a Phase III, randomized, double-blind, multicenter, prospective, comparative study of fluconazole versus voriconazole for the prevention of fungal infections in allogeneic transplant recipients. Recipients will be stratified by center and donor type (sibling vs. unrelated) and will be randomized to either the fluconazole or voriconazole arm in a 1:1 ratio. |
| NCT00075803 ↗ | Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) | Completed | National Marrow Donor Program | Phase 3 | 2003-11-01 | The study is designed as a Phase III, randomized, double-blind, multicenter, prospective, comparative study of fluconazole versus voriconazole for the prevention of fungal infections in allogeneic transplant recipients. Recipients will be stratified by center and donor type (sibling vs. unrelated) and will be randomized to either the fluconazole or voriconazole arm in a 1:1 ratio. |
| NCT00075803 ↗ | Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) | Completed | Medical College of Wisconsin | Phase 3 | 2003-11-01 | The study is designed as a Phase III, randomized, double-blind, multicenter, prospective, comparative study of fluconazole versus voriconazole for the prevention of fungal infections in allogeneic transplant recipients. Recipients will be stratified by center and donor type (sibling vs. unrelated) and will be randomized to either the fluconazole or voriconazole arm in a 1:1 ratio. |
| NCT00166166 ↗ | Endothelial Hyperpolarization in Humans | Terminated | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 | 2002-07-01 | The purpose of this study is to elucidate the role Endothelium-Derived Hyperpolarizing Factor (EDHF) plays in dilating blood vessels and whether it differs between healthy people and those with high cholesterol. A second purpose of the study is to determine the identity of EDHF. |
| NCT00166166 ↗ | Endothelial Hyperpolarization in Humans | Terminated | Emory University | Phase 2 | 2002-07-01 | The purpose of this study is to elucidate the role Endothelium-Derived Hyperpolarizing Factor (EDHF) plays in dilating blood vessels and whether it differs between healthy people and those with high cholesterol. A second purpose of the study is to determine the identity of EDHF. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Diflucan In Sodium Chloride 0.9%
Condition Name
Clinical Trial Locations for Diflucan In Sodium Chloride 0.9%
Trials by Country
Clinical Trial Progress for Diflucan In Sodium Chloride 0.9%
Clinical Trial Phase
Clinical Trial Sponsors for Diflucan In Sodium Chloride 0.9%
Sponsor Name
